Group One Trading, L.P. Gossamer Bio, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 233,170 shares of GOSS stock, worth $529,295. This represents 0.01% of its overall portfolio holdings.
Number of Shares
233,170
Previous 207,744
12.24%
Holding current value
$529,295
Previous $228,000
25.44%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding GOSS
# of Institutions
145Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$41.7 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.1 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$25.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.3 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.2 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $213M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...